fbpx Skip to main content

In this MD Newsline exclusive interview with oncologist Dr. Onyemaechi Okolo, we discuss cancer survival and cancer mortality among Black Americans. We also discuss how a patient’s socioeconomic status and education level impact their cancer management.

MD Newsline:

Why do Black Americans have the highest mortality rate and shortest survival of any racial/ethnic group in the United States for most cancers?

Dr. Onyemaechi Okolo:

“The simple answer is that there’s no one simple answer, unfortunately. The cause of cancer survival disparities in the U.S. is multifactorial. It stems from decades of neglect and marginalization, all of which culminate in systemic issues, like lack of access to healthcare.

Several studies show that cancer survival is intrinsically linked to insurance status and early diagnosis, followed by access to the best possible treatment options. Unfortunately, compared to white Americans, Black Americans and Hispanic Americans have lower levels of health insurance coverage.

Data from 2017 show that 93.7% of white Americans had health insurance coverage compared to 89.4% of African Americans. So this lack of health insurance coverage contributes to why Black Americans have the highest mortality rates for all cancers combined compared to any other racial or ethnic group.”

 

MD Newsline:

How do socioeconomic status and education impact cancer management?

Dr. Onyemaechi Okolo:

“So, again, the answers to this question come down to access. Individuals in higher socioeconomic groups also tend to be the same individuals with higher levels of education. These individuals tend to have consistent healthcare coverage, which allows for appropriate cancer screening, early detection, and thus early disease management.

You May Also Like::  Can Biosimilars help in implementing a value-based care approach in hematology-oncology?

When one is better educated, one tends to be more comfortable asking the hard questions about their options, as well as feeling more comfortable advocating for themselves. And when the insurance is the primary determinant for which treatments will be covered, it can also limit choice, especially if one doesn’t have great insurance coverage.

So, let’s face it. Cancer treatment in the U.S. isn’t cheap and is virtually unaffordable without insurance. Oncologists will try their best to advocate and do their best for their patients, but as you can imagine, they face a lot of roadblocks.”

 

Responses have been condensed and lightly edited.

Share this article